Google's new 27 billion parameter AI model discovers that combining silmitasertib with low-dose interferon can convert immune-resistant 'cold' tumors into 'hot' targets for immunotherapy, with lab tests confirming a 50% boost in immune recognition.
Salesforce and Anthropic expand their partnership to deliver Claude AI models through the Agentforce 360 Platform specifically for regulated industries like financial services and healthcare, making Anthropic the first AI provider fully integrated within Salesforce's secure virtual private cloud environment.
OpenAI signs massive $300 billion five-year cloud infrastructure deal with Oracle despite posting $5 billion loss in 2024, as ChatGPT reaches 800 million weekly users and companies plan joint deployment of 10 gigawatts of custom AI processors.
Stanford researchers unveil OpenTSLM, a groundbreaking AI model that crushes GPT-4o in medical analysis by 350%, achieving 92.9% accuracy in ECG interpretations while using 60% less computing power and providing human-readable explanations for complex medical time-series data.
AstraZeneca strikes a massive $555 million partnership with Algen Biotechnologies, combining cutting-edge AI platform 'AlgenBrain' with CRISPR gene technology to revolutionize drug discovery for chronic inflammatory diseases and unlock next-generation immunology therapies.
Chinese youth increasingly turn to AI chatbots like DeepSeek and Doubao for mental health support as traditional therapy remains costly and inaccessible, with nearly half using AI for psychological discussions despite risks including inappropriate crisis responses and potential social isolation.
AI agents powered by large language models now assist scientists with research tasks like data curation and literature reviews, while new collaborative systems mimic medical teams to analyze drug trials and identify unexpected therapeutic effects, though current technology still requires human oversight due to reliability limitations.
MIT and McMaster University researchers use AI to discover enterololin, a revolutionary narrow-spectrum antibiotic that targets harmful gut bacteria causing Crohn's disease while preserving beneficial microbes, showing promising results in mouse studies and advancing toward human trials.
Stanford researchers use AI to successfully create 16 functional viruses capable of killing bacteria, prompting urgent biosecurity warnings that the technology could enable rapid bioweapon development by bad actors faster than current defense systems can respond.
GreenBitAI launches Libra, the world's first offline AI agent that generates professional documents locally on consumer laptops, using breakthrough technology that shrinks model size by 75% while targeting financial, healthcare, legal, and academic sectors with enterprise-level precision.